| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | BFLY Butterfly Network, Inc. | Stoica Andrei G53 | Chief Technology Officer | Sell | 11,277 | $3.37 | $37,969.66 | -0.8% | -3.6% | -7.6% | |
| Dec 5, 2024 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 5,000 | $2.01 | $10,072.00 | +0.5% | -86.5% | -99.6% | |
| Dec 5, 2024 | RPID Rapid Micro Biosystems, Inc. | Pei Melinda Litherland88 | Director | Buy | 20,000 | $1.02 | $20,363.89 | +25.2% | +164.1% | +286.4% | |
| Dec 5, 2024 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 975 | $12.46 | $12,151.75 | +2.1% | -31.5% | -71.9% | |
| Dec 4, 2024 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 28,092 | $97.13 | $2,728,573.90 | -12.9% | -34.7% | -64.4% | |
| Dec 4, 2024 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 7,618 | $30.00 | $228,540.00 | -18.5% | -15.4% | +53.2% | |
| Dec 4, 2024 | RMD Resmed Inc | Farrell Peter C55 | Director | Sell | 2,000 | $245.65 | $491,300.00 | -2.4% | -5.8% | +2.3% | |
| Dec 4, 2024 | ESTA Establishment Labs Holdings Inc. | Jw Asset Management, LLC65 | 10% Owner | Sell | 100,000 | $45.15 | $4,515,000.00 | -3.1% | +4.6% | +60.1% | |
| Dec 4, 2024 | CATX Perspective Therapeutics, Inc. | Spoor Johan M. | CEO | Buy | 8,000 | $3.77 | $30,132.00 | +28.3% | -36.7% | -35.6% | |
| Dec 4, 2024 | CATX Perspective Therapeutics, Inc. | Henson Heidi | Director | Buy | 25,975 | $3.85 | $100,003.75 | New | -36.7% | -35.6% | |
| Dec 4, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 26,423 | $97.22 | $2,568,844.46 | -4.0% | -34.7% | -64.4% | |
| Dec 4, 2024 | HOLX Hologic Inc | Mitchell Essex D52 | Chief Operating Officer | Sell | 24,856 | $76.34 | $1,897,482.18 | -47.1% | -19.0% | -2.6% | |
| Dec 4, 2024 | ELMD Electromed, Inc. | Summers Andrew79 | Director | Sell | 65,630 | $30.12 | $1,976,605.86 | -3.4% | -12.6% | -6.7% | |
| Dec 3, 2024 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 36,163 | $22.61 | $817,645.43 | -74.6% | +5.8% | -16.5% | |
| Dec 3, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 463 | $13.50 | $6,251.33 | -0.9% | -37.6% | -77.9% | |
| Dec 3, 2024 | IART Integra Lifesciences Holdings Corp | Schwartz Eric | EVP, Chief Legal Officer &Sec | Sell | 4,070 | $24.60 | $100,101.65 | -6.4% | -8.7% | -45.2% | |
| Dec 3, 2024 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 36,163 | $22.61 | $817,645.43 | -74.8% | +5.8% | -16.5% | |
| Dec 3, 2024 | WRBY Warby Parker Inc. | Miller Steven Clive64 | Chief Financial Officer | Sell | 14,853 | $22.61 | $335,826.33 | -7.3% | +5.8% | -16.5% | |
| Dec 3, 2024 | RBOT Vicarious Surgical Inc. | Mazzola John71 | Chief Operating Officer | Sell | 228 | $13.37 | $3,047.33 | -2.3% | -37.6% | -77.9% | |
| Dec 3, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 218 | $13.41 | $2,923.25 | -1.7% | -37.6% | -77.9% | |
| Dec 3, 2024 | MODD Modular Medical, Inc. | Manchester Management Co LLC | 10% Owner, Director By Deputization | Buy | 21,000 | $1.68 | $35,235.90 | +8.6% | -54.3% | -74.9% | |
| Dec 3, 2024 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Buy | 50 | $90.29 | $4,514.60 | - | +15.9% | +9.0% | |
| Dec 3, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 239 | $13.46 | $3,216.75 | -0.6% | -37.6% | -77.9% | |
| Dec 3, 2024 | VERO Venus Concept Inc. | Natale Anthony77 | - | Sell | 42,768 | $0.31 | $13,193.93 | -100% | -11.7% | -48.1% | |
| Dec 3, 2024 | SGHT Sight Sciences, Inc. | Raheja Manohar K.73 | EVP, Research &Development | Buy | 3,376 | $3.89 | $13,132.64 | +3.3% | -35.0% | +121.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.